Clinical TopicsNewsWeb Exclusives

FDA grants to stimulate product development for rare diseases


On Oct. 17, the Food and Drug Administration (FDA) announced that it has awarded more than $23 million in research grants over the next 4 years to boost the development of products for patients with rare diseases. Read more

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


More Perspectives